Results 181 to 190 of about 599,269 (342)

High-resolution fecal pharmacokinetic modeling in mice with orally administered antibiotics. [PDF]

open access: yesSci Rep
Maskawa R   +9 more
europepmc   +1 more source

Fospropofol: Pharmacokinetics?

open access: yesJournal of Anaesthesiology Clinical Pharmacology, 2012
Bharti Mahajan   +2 more
openaire   +3 more sources

Optogenetic‐Controlled iPSC‐Based Vaccines for Prophylactic and Therapeutic Tumor Suppression in Mice

open access: yesAdvanced Science, EarlyView.
This study develops an a red/far‐red light‐controlled iPSC‐based vaccines (RIVA) based on the chimeric photosensory protein FnBphP and its interaction partner LDB3 for cancer immunotherapy. The RIVA preserves the multiple intrinsic tumor antigens of iPSCs and enables optogenetic control of the expression of the immune adjuvant type I interferon β under
Longliang Qiao   +17 more
wiley   +1 more source

PHARMACOKINETICS

open access: yesBritish Journal of Anaesthesia, 1981
openaire   +2 more sources

Restoration of SIRT3 Expression in Aged Mice Alleviates UUO‐Induced Renal Fibrosis by Reducing GSK‐3β Hyperacetylation

open access: yesAdvanced Science, EarlyView.
SIRT3 expression is significantly downregulated in the aged kidney, rendering the kidney more vulnerable to fibrotic changes in obstructive nephropathy. By promoting GSK‐3β deacetylation, SIRT3 indirectly inhibits Wnt/β‐catenin signaling, thereby suppressing renal fibrosis.
Jing Wang   +11 more
wiley   +1 more source

Cefamandole: In Vitro and Clinical Pharmacokinetics

open access: green, 1976
R. S. Griffith   +3 more
openalex   +1 more source

Discovery of Natural Compound α‐Hederin via Large‐Scale Screening as a Targeted JAK/STAT3 Inhibitor for Ovarian Cancer Therapy

open access: yesAdvanced Science, EarlyView.
This study identifies α‐Hederin as a potent dual JAK1/JAK2 inhibitor that blocks STAT3 activation in ovarian cancer. By disrupting STAT3‐driven transcriptional programs, α‐Hederin suppresses tumor proliferation, invasion, and EMT, while enhancing cisplatin efficacy and overcoming chemoresistance.
Jiayu Wang   +9 more
wiley   +1 more source

Advanced human FcRn knock-in mice for pharmacokinetic profiling of therapeutic antibodies. [PDF]

open access: yesSci Rep
Lee S   +9 more
europepmc   +1 more source

Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations [PDF]

open access: yes, 1990
Cadoff, E   +6 more
core  

Home - About - Disclaimer - Privacy